T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity-Reference-Cited by-同舟云学术

T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity

Published:2023-07 Issue:7 Volume:42 Page:112797
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Cui Yuanbin,Yuan Tingjie,Wang Ying,Zheng Diwei,Qin Le,Li Shanglin,Jiang Zhiwu,Lin Shouheng,Guo Wenjing,Wang Zhi,Liang Zhaoduan,Li Yi,Yao Yao,Liu Xingguo,Tang Qiannan,Tu Hai-Yan,Zhang Xu-Chao,Tang Zhaoyang,Wong Nathalie,Zhang Zhenfeng,Qin Dajiang,Thiery Jean Paul,Xu Kailin,Li Peng^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference67 articles.

1. Advances in the assessment and control of the effector functions of therapeutic antibodies;Jiang;Nat. Rev. Drug Discov.,2011

2. Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape;Ferris;J. Clin. Oncol.,2010

3. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial;Cameron;Lancet,2017

4. Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience;Salles;Adv. Ther.,2017

5. Fc receptor-dependent mechanisms of monoclonal antibody therapy of cancer;Bakema;Curr. Top. Microbiol. Immunol.,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression;Acta Pharmaceutica Sinica B;2024-09

2. Broadening anticancer spectrum by preprocessing and treatment of T- lymphocytes expressed FcγRI and monoclonal antibodies for refractory cancers;Frontiers in Immunology;2024-06-17

3. CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies;Frontiers in Immunology;2024-04-12

4. CAR designs for solid tumors: overcoming hurdles and paving the way for effective immunotherapy;Biophysics Reports;2023